Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP207612.RA5Q9Z9KYsNYuqiqaL5cDBfUpDiO2Gv_np7ZCOxWJ7FBg130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP207612.RA5Q9Z9KYsNYuqiqaL5cDBfUpDiO2Gv_np7ZCOxWJ7FBg130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP207612.RA5Q9Z9KYsNYuqiqaL5cDBfUpDiO2Gv_np7ZCOxWJ7FBg130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP207612.RA5Q9Z9KYsNYuqiqaL5cDBfUpDiO2Gv_np7ZCOxWJ7FBg130_provenance.
- NP207612.RA5Q9Z9KYsNYuqiqaL5cDBfUpDiO2Gv_np7ZCOxWJ7FBg130_assertion description "[We hypothesized that: 1) CD1 expression increases with disease progression to advanced SCC, and 2) AS-cyclin D1 therapy would lead to prolonged tumor regression in a xenograft model of human SCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP207612.RA5Q9Z9KYsNYuqiqaL5cDBfUpDiO2Gv_np7ZCOxWJ7FBg130_provenance.
- NP207612.RA5Q9Z9KYsNYuqiqaL5cDBfUpDiO2Gv_np7ZCOxWJ7FBg130_assertion evidence source_evidence_literature NP207612.RA5Q9Z9KYsNYuqiqaL5cDBfUpDiO2Gv_np7ZCOxWJ7FBg130_provenance.
- NP207612.RA5Q9Z9KYsNYuqiqaL5cDBfUpDiO2Gv_np7ZCOxWJ7FBg130_assertion SIO_000772 10690551 NP207612.RA5Q9Z9KYsNYuqiqaL5cDBfUpDiO2Gv_np7ZCOxWJ7FBg130_provenance.
- NP207612.RA5Q9Z9KYsNYuqiqaL5cDBfUpDiO2Gv_np7ZCOxWJ7FBg130_assertion wasDerivedFrom befree-20140225 NP207612.RA5Q9Z9KYsNYuqiqaL5cDBfUpDiO2Gv_np7ZCOxWJ7FBg130_provenance.
- NP207612.RA5Q9Z9KYsNYuqiqaL5cDBfUpDiO2Gv_np7ZCOxWJ7FBg130_assertion wasGeneratedBy ECO_0000203 NP207612.RA5Q9Z9KYsNYuqiqaL5cDBfUpDiO2Gv_np7ZCOxWJ7FBg130_provenance.
- befree-20140225 importedOn "2014-02-25" NP207612.RA5Q9Z9KYsNYuqiqaL5cDBfUpDiO2Gv_np7ZCOxWJ7FBg130_provenance.